The Louisiana-based company offers its Ellipse Spinal Cord Stimulator Platform for treating chronic pain. The platform includes the company's patented and FDA-cleared StimuLux technology, which uses ...

ReShape Lifesciences announced the granting of an international patent for its Diabetes Neuromodulation technology, which combines proprietary vagus nerve modulation with vagal stimulation aimed at ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

TAMPA, Fla. & NETANYA, Israel--(BUSINESS WIRE)--Neurolief, an innovator in neurotechnology, announces the company has received Food and Drug Administration (FDA) clearance for its Relivion® system.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Presidio Medical, Inc., a clinical-stage medical technology company developing a transformational neuromodulation platform, today announced research ...

PLANO, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, ...

Pictured is the complete ExaStim® Stimulation System. · GlobeNewswire Inc. Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- ANEUVO (Niche Biomedical, Inc. d.b.a. ANEUVO), a medical technology ...

The company's core technology is based on neuromodulation, using target electrical impulses to trigger specific physiological responses in the human body's central nervous system. Using electrical ...

IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences (RSLS) ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the ...

IRVINE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences (RSLS) ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the ...